ibuprofen has been researched along with Arthritis in 89 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Arthritis: Acute or chronic inflammation of JOINTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients who required NSAIDs for osteoarthritis or rheumatoid arthritis and were at increased cardiovascular risk were randomly assigned to receive celecoxib, ibuprofen, or naproxen." | 9.22 | Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. ( Bao, W; Beckerman, B; Berger, MF; Borer, JS; Gaffney, M; Graham, DY; Husni, ME; Libby, P; Lincoff, AM; Lüscher, TF; Menon, V; Nissen, SE; Ruschitzka, F; Solomon, DH; Wang, Q; Wisniewski, LM; Wolski, KE; Yeomans, ND, 2016) |
| "Etretinate (Tigason) and ibuprofen have been compared in a double-blind controlled trial in psoriatic arthritis to see if we could confirm a specific action for this vitamin A derivative suggested from earlier uncontrolled studies." | 9.05 | A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis. ( Astbury, C; Bird, HA; Hill, J; Hopkins, R; Jones, H; Miller, A; Surrall, KE; Wright, V, 1985) |
| " We report the first case of nephrogenic adenoma of the bladder in a 53-year-old man with a 5-year history of ibuprofen abuse for chronic arthritis." | 7.72 | Nephrogenic adenoma of bladder after ibuprofen abuse. ( Bartoletti, R; Crisci, A; Di Loro, F; Giubilei, G; Mondaini, N; Scelzi, S, 2004) |
| "Eight patients with arthritis and knee effusions received 13 doses of a single 800-mg ibuprofen tablet every 8 hours." | 7.68 | Pharmacokinetics of the R(-) and S(+) enantiomers of ibuprofen in the serum and synovial fluid of arthritis patients. ( Cox, SR; Forbes, KK; Gall, EP; Goris, G; Gresham, M, 1991) |
| "Antiinflammatory effect of ibuprofen was studied in the model of adjuvant arthritis in rats." | 7.67 | Proteolytic and beta-glucuronidase activity in adjuvant arthritis during the ibuprofen therapy. ( Pawłowski, K, 1985) |
| "The effect of prolonged treatment with etodolac (8 mg/kg) on the articular and bone pathology at the tibiotarsal joint associated with adjuvant arthritis in the rat has been studied and compared to the effects produced by treatment with naproxen (8 mg/kg) and ibuprofen (50 mg/kg)." | 7.67 | Comparative effects of long term treatment with etodolac, naproxen and ibuprofen on articular and bone changes associated with adjuvant arthritis in rats. ( Klicius, J; Martel, RR; Metcalf, G; Rona, GA, 1984) |
| "Anti-inflammatory effect of ibuprofen was studied on the model of adjuvant arthritis." | 7.67 | Haptoglobin and copper in adjuvant arthritis during the ibuprofen therapy. ( Pawłowski, K, 1984) |
| "Concentrations of Ibuprofen and Protein Concentration and pH-Value in Synovial Fluid and Plasma Following Oral Administration of Ibuprofen in Patients Suffering from Arthritis." | 7.67 | [Concentrations of ibuprofen and the protein and pH value of synovial fluid and plasma following oral administration of ibuprofen in patients with arthritis]. ( Berner, G; Rau, R; Vögtle-Junkert, U; Wagener, HH, 1989) |
| "A patient with systemic lupus erythematosus had chills, fever, and headache on four separate occasions after ibuprofen ingestion." | 5.26 | Ibuprofen-induced meningitis in systemic lupus erythematosus. ( Littman, BH; Widener, HL, 1978) |
| "Patients who required NSAIDs for osteoarthritis or rheumatoid arthritis and were at increased cardiovascular risk were randomly assigned to receive celecoxib, ibuprofen, or naproxen." | 5.22 | Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. ( Bao, W; Beckerman, B; Berger, MF; Borer, JS; Gaffney, M; Graham, DY; Husni, ME; Libby, P; Lincoff, AM; Lüscher, TF; Menon, V; Nissen, SE; Ruschitzka, F; Solomon, DH; Wang, Q; Wisniewski, LM; Wolski, KE; Yeomans, ND, 2016) |
| " We studied 17 women with arthritis and hypertension who were receiving fosinopril and HCTZ, and administered sequentially in random order ibuprofen, sulindac, and nabumetone for 1 month each, with an intervening 2-week washout period between each treatment period." | 5.09 | Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs. ( Cook, ME; Thakur, V; Wallin, JD, 1999) |
| "Etretinate (Tigason) and ibuprofen have been compared in a double-blind controlled trial in psoriatic arthritis to see if we could confirm a specific action for this vitamin A derivative suggested from earlier uncontrolled studies." | 5.05 | A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis. ( Astbury, C; Bird, HA; Hill, J; Hopkins, R; Jones, H; Miller, A; Surrall, KE; Wright, V, 1985) |
| " In a cohort study comparing the risk of upper gastrointestinal complications in celecoxib or traditional NSAIDs (diclofenac, ibuprofen) initiators with rheumatoid arthritis and osteoarthritis, we (1) aggregated medications and International Classification of Diseases-9 (ICD-9) diagnoses into hierarchies of the Anatomical Therapeutic Chemical classification (ATC) and the Clinical Classification Software (CCS), respectively, and (2) sampled the full cohort using techniques validated by simulations to create 9,600 samples to compare 16 aggregation scenarios across 50% and 20% samples with varying outcome incidence and exposure prevalence." | 3.79 | Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example. ( Beach, KJ; Brookhart, MA; Layton, JB; Le, HV; Poole, C; Schoenbach, VJ; Stürmer, T, 2013) |
| "Ibuprofen was the first of a new breed of NSAIDs originally introduced into the United Kingdom in 1969." | 3.76 | Update on ibuprofen: review article. ( Busson, M, 1986) |
| "To estimate the net cardiovascular (CV) (coronary heart disease, stroke, congestive heart failure), and gastrointestinal (GI) (peptic ulcer complications) risk-benefit public health impact of the use of celecoxib compared to non-selective NSAIDs in the arthritis population." | 3.74 | Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. ( Castellsague, J; Maguire, A; Perez-Gutthann, S; Varas-Lorenzo, C, 2007) |
| " We report the first case of nephrogenic adenoma of the bladder in a 53-year-old man with a 5-year history of ibuprofen abuse for chronic arthritis." | 3.72 | Nephrogenic adenoma of bladder after ibuprofen abuse. ( Bartoletti, R; Crisci, A; Di Loro, F; Giubilei, G; Mondaini, N; Scelzi, S, 2004) |
| "Eight patients with arthritis and knee effusions received 13 doses of a single 800-mg ibuprofen tablet every 8 hours." | 3.68 | Pharmacokinetics of the R(-) and S(+) enantiomers of ibuprofen in the serum and synovial fluid of arthritis patients. ( Cox, SR; Forbes, KK; Gall, EP; Goris, G; Gresham, M, 1991) |
| "The effect of prolonged treatment with etodolac (8 mg/kg) on the articular and bone pathology at the tibiotarsal joint associated with adjuvant arthritis in the rat has been studied and compared to the effects produced by treatment with naproxen (8 mg/kg) and ibuprofen (50 mg/kg)." | 3.67 | Comparative effects of long term treatment with etodolac, naproxen and ibuprofen on articular and bone changes associated with adjuvant arthritis in rats. ( Klicius, J; Martel, RR; Metcalf, G; Rona, GA, 1984) |
| "Anti-inflammatory effect of ibuprofen was studied on the model of adjuvant arthritis." | 3.67 | Haptoglobin and copper in adjuvant arthritis during the ibuprofen therapy. ( Pawłowski, K, 1984) |
| "Concentrations of Ibuprofen and Protein Concentration and pH-Value in Synovial Fluid and Plasma Following Oral Administration of Ibuprofen in Patients Suffering from Arthritis." | 3.67 | [Concentrations of ibuprofen and the protein and pH value of synovial fluid and plasma following oral administration of ibuprofen in patients with arthritis]. ( Berner, G; Rau, R; Vögtle-Junkert, U; Wagener, HH, 1989) |
| "A case of Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriasis and psoriatic arthropathy is described." | 3.67 | Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriatic arthropathy. ( Constable, TJ; Ryatt, KS; Wallis, PJ, 1989) |
| "The dual inhibitors of arachidonic acid metabolism, Smith Kline & French (SK&F) 86002, SK&F 104351, and phenidone; the corticosteroid, dexamethasone; and the selective cyclooxygenase inhibitors, ibuprofen, indomethacin, naproxen, and piroxicam were evaluated for their antiarthritic potency in the murine, collagen-induced arthritis model." | 3.67 | Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. ( DiMartino, MJ; Griswold, DE; Hanna, N; Hillegass, LM; Meunier, PC, 1988) |
| "Antiinflammatory effect of ibuprofen was studied in the model of adjuvant arthritis in rats." | 3.67 | Proteolytic and beta-glucuronidase activity in adjuvant arthritis during the ibuprofen therapy. ( Pawłowski, K, 1985) |
| "Three young women with systemic lupus erythematosus who were given ibuprofen for arthritis voluntarily discontinued taking the drug." | 3.66 | Acute adverse reactions to ibuprofen in systemic lupus erythematosus. ( Finch, WR; Strottman, MP, 1979) |
| "Ibuprofen has been shown to be effective in rheumatoid arthritis and osteoarthritis and is probably effective in ankylosing spondylitis, gout, and Bartter's syndrome." | 2.36 | Ibuprofen. ( Kantor, TG, 1979) |
| "Sweet's syndrome (SS) or acute febrile neutrophilic dermatosis is an uncommon condition." | 1.48 | Sweet's syndrome: a clinical entity need to discriminate against acute haematogenous periprosthetic joint infection. ( Chung, MJ; Kim, KB; Lee, JH; Lee, JR; Wang, SI, 2018) |
| "We tested whether this parameter and tactile allodynia, the standard pain measure in preclinical studies, show parallels in their response to analgesics and basic mechanisms." | 1.46 | Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia. ( Cañizares, FJ; Cobos, EJ; Entrena, JM; Fernández-Segura, E; Montilla-García, Á; Perazzoli, G; Portillo-Salido, E; Tejada, MÁ, 2017) |
| " Currently available in the market are preparations in which bioavailability of ibuprofen is increased by salification with various salts." | 1.35 | Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects. ( Cattaneo, D; Clementi, E; Cuzzocrea, S; De Palma, C; Di Paola, R; Mazzon, E; Perrotta, C; Trabucchi, E, 2009) |
| " Etoricoxib is partly metabolised by the cytochrome P450 isoenzyme CYP 3A4 and increases the bioavailability of ethinylestradiol." | 1.34 | Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain. ( , 2007) |
| " The antinociceptive efficacies were evaluated using several dose-response curves and time courses." | 1.33 | Enhancement of antinociception by co-administration of ibuprofen and caffeine in arthritic rats. ( Bravo, G; Cook, HJ; Déciga-Campos, M; Díaz-Reval, MI; Domínguez-Ramírez, AM; López, JR; López-Muñoz, FJ, 2006) |
| "Celecoxib users were 4." | 1.32 | Persistence with COX-2 inhibitors in managed care: an analysis of claims data. ( Harley, C; Wagner, S, 2003) |
| "This syndrome was first described by Schnitzler et al." | 1.29 | [Schnitzler syndrome]. ( Itin, PH; Lautenschlager, S, 1993) |
| " AD-1590 and indomethacin at an oral dosage as high as 32 mg/kg did not show any significant inhibitory activity on rat passive cutaneous anaphylaxis, a type-I allergy, although prednisolone and cyproheptadine produced strong inhibition." | 1.27 | [Inhibitory effect of AD-1590, a non-steroidal anti-inflammatory drug, on allergic inflammation in mice and rats]. ( Ishii, K; Kadokawa, T; Motoyoshi, S; Nakamura, H, 1988) |
| "A patient with systemic lupus erythematosus had chills, fever, and headache on four separate occasions after ibuprofen ingestion." | 1.26 | Ibuprofen-induced meningitis in systemic lupus erythematosus. ( Littman, BH; Widener, HL, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (46.07) | 18.7374 |
| 1990's | 12 (13.48) | 18.2507 |
| 2000's | 20 (22.47) | 29.6817 |
| 2010's | 16 (17.98) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lazer, ES | 1 |
| Matteo, MR | 1 |
| Possanza, GJ | 1 |
| Shenvi, S | 1 |
| Kiran, KR | 1 |
| Kumar, K | 1 |
| Diwakar, L | 1 |
| Reddy, GC | 1 |
| Grosser, T | 1 |
| Nissen, SE | 3 |
| Montilla-García, Á | 1 |
| Tejada, MÁ | 1 |
| Perazzoli, G | 1 |
| Entrena, JM | 1 |
| Portillo-Salido, E | 1 |
| Fernández-Segura, E | 1 |
| Cañizares, FJ | 1 |
| Cobos, EJ | 1 |
| Lee, JH | 1 |
| Kim, KB | 1 |
| Lee, JR | 1 |
| Chung, MJ | 1 |
| Wang, SI | 1 |
| Fernández-Ruiz, I | 1 |
| Weintraub, WS | 1 |
| Laine, L | 1 |
| Yeomans, ND | 3 |
| Graham, DY | 3 |
| Dumpa, NR | 1 |
| Sarabu, S | 1 |
| Bandari, S | 1 |
| Zhang, F | 1 |
| Repka, MA | 1 |
| Le, HV | 1 |
| Poole, C | 1 |
| Brookhart, MA | 1 |
| Schoenbach, VJ | 1 |
| Beach, KJ | 1 |
| Layton, JB | 1 |
| Stürmer, T | 1 |
| Tofield, A | 1 |
| Solomon, DH | 2 |
| Lüscher, TF | 2 |
| Libby, P | 2 |
| Husni, ME | 2 |
| Borer, JS | 2 |
| Wisniewski, LM | 1 |
| Wolski, KE | 1 |
| Wang, Q | 1 |
| Menon, V | 1 |
| Ruschitzka, F | 2 |
| Gaffney, M | 1 |
| Beckerman, B | 1 |
| Berger, MF | 1 |
| Bao, W | 1 |
| Lincoff, AM | 2 |
| González-Gay, MA | 1 |
| González-Juanatey, C | 1 |
| Becker, MC | 1 |
| Wang, TH | 1 |
| Wisniewski, L | 1 |
| Wolski, K | 1 |
| Mascette, AM | 1 |
| Krum, H | 1 |
| De Palma, C | 1 |
| Di Paola, R | 1 |
| Perrotta, C | 1 |
| Mazzon, E | 1 |
| Cattaneo, D | 1 |
| Trabucchi, E | 1 |
| Cuzzocrea, S | 1 |
| Clementi, E | 1 |
| Yinh, J | 1 |
| Pilichowska, M | 1 |
| Kalish, R | 1 |
| Kikuchi, T | 1 |
| Okada, M | 1 |
| Nengaki, N | 1 |
| Furutsuka, K | 1 |
| Wakizaka, H | 1 |
| Okamura, T | 1 |
| Zhang, MR | 1 |
| Kato, K | 1 |
| Woodruff, TM | 1 |
| Strachan, AJ | 1 |
| Dryburgh, N | 1 |
| Shiels, IA | 1 |
| Reid, RC | 1 |
| Fairlie, DP | 1 |
| Taylor, SM | 1 |
| Francis, GS | 1 |
| Nicolas, X | 1 |
| Vaillant, PY | 1 |
| Bellard, S | 1 |
| Harley, C | 1 |
| Wagner, S | 1 |
| Scelzi, S | 1 |
| Giubilei, G | 1 |
| Bartoletti, R | 1 |
| Di Loro, F | 1 |
| Mondaini, N | 1 |
| Crisci, A | 1 |
| Hollenz, M | 1 |
| Labenz, J | 1 |
| Ecker-Schlipf, B | 1 |
| Peng, YS | 1 |
| Lin, SC | 1 |
| Huang, SJ | 1 |
| Wang, YM | 1 |
| Lin, YJ | 1 |
| Wang, LF | 1 |
| Chen, JS | 1 |
| López, JR | 1 |
| Domínguez-Ramírez, AM | 1 |
| Cook, HJ | 1 |
| Bravo, G | 1 |
| Díaz-Reval, MI | 1 |
| Déciga-Campos, M | 1 |
| López-Muñoz, FJ | 1 |
| Varas-Lorenzo, C | 1 |
| Maguire, A | 1 |
| Castellsague, J | 1 |
| Perez-Gutthann, S | 1 |
| Hawkey, CJ | 1 |
| Weinstein, WM | 1 |
| Stricker, K | 1 |
| Murphy, V | 1 |
| Richard, D | 1 |
| Krammer, G | 1 |
| Rebuli, R | 1 |
| Martel, RR | 1 |
| Klicius, J | 1 |
| Metcalf, G | 1 |
| Rona, GA | 1 |
| Bhalla, AK | 1 |
| Simon, LS | 3 |
| Pawłowski, K | 2 |
| Obel, AO | 1 |
| Rosenthal, M | 1 |
| Gever, LN | 1 |
| Bunton, RW | 1 |
| Barrett, DC | 1 |
| Palmer, DG | 1 |
| Mills, JA | 1 |
| Fischer, M | 1 |
| Nash, DP | 1 |
| Reid, AL | 1 |
| Smith, DL | 1 |
| Regan, MG | 1 |
| Whitlam, JB | 1 |
| Brown, KF | 1 |
| Crooks, MJ | 1 |
| Room, GF | 1 |
| Lems, WF | 1 |
| van Berge Henegouwen, GP | 1 |
| Bijlsma, JW | 1 |
| Locatelli, L | 2 |
| Sacerdote, P | 2 |
| Mantegazza, P | 1 |
| Panerai, AE | 2 |
| Kiff, PS | 1 |
| Stead, H | 1 |
| Morant, SV | 1 |
| Shield, MJ | 1 |
| LeLorier, J | 1 |
| Lautenschlager, S | 1 |
| Itin, PH | 1 |
| Davis, BJ | 1 |
| Thompson, J | 1 |
| Peimann, A | 1 |
| Bendixen, BH | 1 |
| Thakur, V | 1 |
| Cook, ME | 1 |
| Wallin, JD | 1 |
| Lindahl, G | 1 |
| Perman, E | 1 |
| Jüni, P | 1 |
| Rutjes, AW | 1 |
| Dieppe, PA | 1 |
| Binderup, L | 1 |
| Bramm, E | 1 |
| Arrigoni-Martelli, E | 1 |
| Oyemade, GA | 1 |
| Onadeko, BO | 1 |
| Widener, HL | 1 |
| Littman, BH | 1 |
| Puranen, J | 1 |
| Rönty, H | 1 |
| D'Amora, T | 1 |
| Kantor, TG | 1 |
| Finch, WR | 1 |
| Strottman, MP | 1 |
| Meyer, HC | 1 |
| Sharma, JN | 2 |
| Korsager, S | 1 |
| Brooks, PM | 1 |
| Sack, KE | 1 |
| Rosenthal, SH | 1 |
| Peruzza, M | 1 |
| Finzi, B | 1 |
| Parini, J | 1 |
| Emanueli, A | 1 |
| Grahame, R | 1 |
| Healey, LA | 1 |
| Scharf, J | 1 |
| Nahir, M | 1 |
| Dickstein, G | 1 |
| Barzilai, D | 1 |
| Cox, SR | 1 |
| Gall, EP | 1 |
| Forbes, KK | 1 |
| Gresham, M | 1 |
| Goris, G | 1 |
| Kaufman, LD | 1 |
| Rau, R | 1 |
| Berner, G | 1 |
| Wagener, HH | 1 |
| Vögtle-Junkert, U | 1 |
| Wallis, PJ | 1 |
| Ryatt, KS | 1 |
| Constable, TJ | 1 |
| Neuman, RG | 1 |
| Wilson, BD | 1 |
| Barkley, M | 1 |
| Kimball, ES | 1 |
| Weichman, BM | 1 |
| Wood, DD | 1 |
| Griswold, DE | 1 |
| Hillegass, LM | 1 |
| Meunier, PC | 1 |
| DiMartino, MJ | 1 |
| Hanna, N | 1 |
| Nakamura, H | 1 |
| Motoyoshi, S | 1 |
| Ishii, K | 1 |
| Kadokawa, T | 1 |
| Busson, M | 1 |
| Hakala, M | 1 |
| Timonen, TT | 1 |
| Rossi, O | 1 |
| Koivisto, O | 1 |
| Koistinen, PO | 1 |
| Hunneyball, IM | 1 |
| Crossley, MJ | 1 |
| Spowage, M | 1 |
| Hopkins, R | 1 |
| Bird, HA | 1 |
| Jones, H | 1 |
| Hill, J | 1 |
| Surrall, KE | 1 |
| Astbury, C | 1 |
| Miller, A | 1 |
| Wright, V | 1 |
| Steven, MM | 1 |
| Small, M | 1 |
| Pinkerton, L | 1 |
| Madhok, R | 1 |
| Sturrock, RD | 1 |
| Forbes, CD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen[NCT00346216] | Phase 4 | 24,081 participants (Actual) | Interventional | 2006-10-04 | Completed | ||
| Single Dose Oral Celecoxib (With or Without Acetaminophen) for Acute Post-operative Pain Following Impacted Third Molar Surgery.[NCT04790812] | Phase 4 | 100 participants (Anticipated) | Interventional | 2021-04-22 | Recruiting | ||
| Use of a Self-Guided Mindfulness Mobile Application to Improve Pain Outcomes in Individuals With Knee Osteoarthritis[NCT03936088] | 75 participants (Actual) | Interventional | 2019-05-02 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"VAS question How much pain do you have was graded on a scale from 0 to 100 with 0 indicating No pain and 100 indicating Worst possible pain." (NCT00346216)
Timeframe: ITT and MITT Population - Baseline to 42 months
| Intervention | Number of participants (Mean) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline (ITT) N= 8014, 8001, 7928 | Change-Baseline to Mon1 (ITT) N=7382, 7379, 7325 | Change-Baseline to Mon2 (ITT) N=7180, 7090, 7149 | Change-Baseline to Mon4 (ITT) N=6777, 6696, 6740 | Change-Baseline to Mon8 (ITT) N=6230, 6137, 6159 | Change-Baseline to Mon12 (ITT) N=5792, 5696, 5846 | Change-Baseline to Mon18 (ITT) N=5310, 5181. 5246 | Change-Baseline to Mon24 (ITT) N=4818, 4776, 4785 | Change-Baseline to Mon30 (ITT) N=4140, 4069, 4086 | Change-Baseline to Mon36 (ITT) N=3692, 3627, 3635 | Change-Baseline to Mon42 (ITT) N=3469, 3406, 3439 | Baseline (MITT) N=7974, 7954, 7894 | Change-Baseline to Mon1 MITT N=7372, 7367, 7321 | Change-Baseline to Mon2 MITT N=7170, 7078, 7142 | Change-Baseline to Mon4 MITT N=6772, 6686, 6732 | Change-Baseline to Mon8 MITT N=6224, 6128, 6155 | Change-Baseline to Mon12 MITT N=5787, 5689, 5844 | Change-Baseline to Mon18 MITT N=5305, 5175, 5242 | Change-Baseline to Mon24 MITT N=4815, 4769, 4782 | Change-Baseline to Mon30 MITT N=4139, 4067, 4085 | Change-Baseline to Mon36 MITT N=3691, 3623, 3635 | Change-Baseline to Mon42 MITT N=3468, 3404, 3438 | |
| Celecoxib | 54.0 | -8.2 | -10.5 | -11.4 | -11.7 | -11.0 | -11.3 | -11.3 | -10.5 | -10.1 | -11.4 | 54.0 | -8.2 | -10.5 | -11.4 | -11.7 | -11.0 | -11.3 | -11.4 | -10.5 | -10.2 | -11.4 |
| Ibuprofen | 54.1 | -9.0 | -10.6 | -11.7 | -12.1 | -11.6 | -11.3 | -11.5 | -11.2 | -10.7 | -11.1 | 54.1 | -9.0 | -10.6 | -11.7 | -12.1 | -11.6 | -11.3 | -11.5 | -11.2 | -10.7 | -11.1 |
| Naproxen | 54.1 | -9.9 | -11.1 | -12.3 | -12.1 | -11.9 | -11.7 | -11.4 | -11.3 | -11.6 | -12.1 | 54.1 | -9.9 | -11.1 | -12.3 | -12.1 | -11.9 | -11.7 | -11.3 | -11.3 | -11.6 | -12.1 |
MACE defined as the composite of CV death (including hemorrhagic death), non-fatal MI, non-fatal stroke, hospitalization for UA, revascularization or hospitalization for TIA (NCT00346216)
Timeframe: ITT Population - 30 months; MITT Population - 42 months
| Intervention | Percentage of Participants (Number) | |
|---|---|---|
| ITT (N = 8072, 8040, 7969) | MITT (N = 8030, 7990, 7933) | |
| Celecoxib | 4.2 | 3.1 |
| Ibuprofen | 4.8 | 3.6 |
| Naproxen | 4.3 | 3.2 |
APTC events are defined as a composite of any of the following events: Death due to CV causes (including cardiac, cerebrovascular, venous thromboembolic, haemorrhagic, other vascular, or unknown cause); Non-fatal MI; Non-fatal stroke (including intracranial hemorrhages, stroke of ischemic or unknown etiology). (NCT00346216)
Timeframe: Intent to Treat (ITT) Population - 30 months; Modified ITT (MITT) Population - 42 months
| Intervention | Percentage of Partcipants (Number) | |
|---|---|---|
| ITT (N = 8072, 8040, 7969) | MITT (N = 8030, 7990, 7933) | |
| Celecoxib | 2.3 | 1.7 |
| Ibuprofen | 2.7 | 1.9 |
| Naproxen | 2.5 | 1.8 |
CSGIE include: Gastroduodenal (GD) hemorrhage, Gastric outlet obstruction, Gastroduodenal, small bowel or large bowel perforation, Large bowel hemorrhage, Small bowel hemorrhage, Acute GI hemorrhage of unknown origin, including presumed small bowel hemorrhage, Symptomatic gastric or duodenal ulcer (NCT00346216)
Timeframe: ITT Population - 30 months; MITT Population - 42 months
| Intervention | Percentage of Participants (Number) | |
|---|---|---|
| ITT (N = 8072, 8040, 7969) | MITT (N = 8030, 7990, 7933) | |
| Celecoxib | 0.7 | 0.3 |
| Ibuprofen | 0.9 | 0.7 |
| Naproxen | 0.7 | 0.7 |
9 reviews available for ibuprofen and Arthritis
| Article | Year |
|---|---|
Hypertension: Ibuprofen increases blood pressure in patients with arthritis.
Topics: Arthritis; Blood Pressure; Global Health; Humans; Hypertension; Ibuprofen; Incidence | 2017 |
Practical therapeutics: the newer nonsteroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents; Arthritis; Aspirin; Diclofenac; Humans; Ibuprofen; Indomethacin; Naproxen; | 1982 |
Nonsteroidal antiinflammatory drugs (second of two parts).
Topics: Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Fenoprofen; Humans; Ibuprofen; Mefenamic | 1980 |
[Piroxicam--a step forward in the treatment of rheumatism].
Topics: Anti-Inflammatory Agents; Arthritis; Humans; Ibuprofen; Indomethacin; Piroxicam; Pyridines; Rheumati | 1980 |
['Stomach-friendly' NSAIDs: careful optimism?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Butanones; Gastritis; Humans; Ibuprofen; Misopro | 1995 |
COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 In | 2001 |
Ibuprofen.
Topics: Analgesics; Anti-Inflammatory Agents; Arthritis; Digestive System; Drug Interactions; Humans; Ibupro | 1979 |
Rheumatoid arthritis: an overview.
Topics: Adult; Arthritis; Arthritis, Reactive; Arthritis, Rheumatoid; Aspirin; Diagnosis, Differential; Fema | 1976 |
Update on ibuprofen: review article.
Topics: Analgesia; Arthritis; Arthritis, Rheumatoid; Clinical Trials as Topic; Connective Tissue Diseases; D | 1986 |
13 trials available for ibuprofen and Arthritis
| Article | Year |
|---|---|
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cycloo | 2016 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cycloo | 2016 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cycloo | 2016 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cycloo | 2016 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cycloo | 2016 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cycloo | 2016 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cycloo | 2016 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cycloo | 2016 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cycloo | 2016 |
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygena | 2009 |
Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment--findings from the Therapeutic Arthritis Research and Gastrointestinal Even
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Cyclooxygenase | 2008 |
Arthrotec, diclofenac and ibuprofen in general practice.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Diclofenac; Drug Combinations; Female; Hum | 1994 |
Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs.
Topics: Acetaminophen; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Ar | 1999 |
A controlled clinical study comparing sulindac with ibuprofen and aspirin in the treatment of musculo-skeletal diseases.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; | 1979 |
A new anti-inflammatory drug, proquazone, and ibuprofen in the treatment of degenerative joint disease of the knee (gonarthrosis). A double-blind comparative study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis; Clinical Trials as Topic; Double-Blind Method; Dru | 1978 |
[Lysine p-isobutylphenylpropionate in the treatment of gonarthroiis].
Topics: Adult; Aged; Arthritis; Clinical Trials as Topic; Drug Tolerance; Female; Humans; Ibuprofen; Knee Jo | 1978 |
Indoprofen in the treatment of osteoarthrosis. A controlled trial in comparison with ibuprofen.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Clinical Trials as Topic; Female; Humans; | 1976 |
Ketoprofen - clinical efficacy.
Topics: Acetaminophen; Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Aspirin; Benzophenones; C | 1976 |
Update on ibuprofen: review article.
Topics: Analgesia; Arthritis; Arthritis, Rheumatoid; Clinical Trials as Topic; Connective Tissue Diseases; D | 1986 |
A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis.
Topics: Adolescent; Adult; Aged; Arthritis; Clinical Trials as Topic; Double-Blind Method; Etretinate; Femal | 1985 |
Non-steroidal anti-inflammatory drugs in haemophilic arthritis. A clinical and laboratory study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis; Blood Platelets; Clinical Trials as Topic; Hemophi | 1985 |
68 other studies available for ibuprofen and Arthritis
| Article | Year |
|---|---|
Benzimidazole derivatives with atypical antiinflammatory activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Benzimidazoles | 1987 |
Synthesis and biological evaluation of boswellic acid-NSAID hybrid molecules as anti-inflammatory and anti-arthritic agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Rats; Rats, Wistar; Triterpenes | 2015 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Humans; Ibuprofen; Naproxen; Pyrazole | 2017 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Humans; Ibuprofen; Naproxen; Pyrazole | 2017 |
Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia.
Topics: Acetaminophen; Analgesics; Animals; Arthritis; Celecoxib; Disease Models, Animal; Diterpenes; Female | 2017 |
Sweet's syndrome: a clinical entity need to discriminate against acute haematogenous periprosthetic joint infection.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthroplasty, Replacement, Knee; Colchicin | 2018 |
Safety of non-steroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Blood Pressure; Blood Pressure Monitoring, Ambul | 2017 |
Editorial: gastrointestinal safety of COX-2 selective and nonselective NSAIDs-the impact of the PRECISION trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 In | 2018 |
Editorial: gastrointestinal safety of COX-2 selective and nonselective NSAIDs-the impact of the PRECISION trial. Authors' reply.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 In | 2018 |
Chronotherapeutic Drug Delivery of Ketoprofen and Ibuprofen for Improved Treatment of Early Morning Stiffness in Arthritis Using Hot-Melt Extrusion Technology.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Calorimetry, Differential Scanning; Delayed-Acti | 2018 |
Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example.
Topics: Adolescent; Adult; Aged; Algorithms; Arthritis; Celecoxib; Confounding Factors, Epidemiologic; Cyclo | 2013 |
Common analgesics 'pose cardiac risk'.
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Diclofenac; Heart Dise | 2014 |
Inflammation: NSAIDs and cardiovascular risk in arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Humans; Ibup | 2017 |
Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Arginine; Arthritis; Drug Combinations; | 2009 |
I prefer ibuprofen over acetaminophen for arthritis pain relief. But now my doctor suggests I take a narcotic pain reliever. Is this safe?
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Humans; Ibuprofen; Narcotics | 2009 |
A 27-year-old Cambodian woman with fever, lymphadenopathy, and arthritis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Asian | 2010 |
Efficient synthesis and chiral separation of 11C-labeled ibuprofen assisted by DMSO for imaging of in vivo behavior of the individual isomers by positron emission tomography.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Carbon Isotopes; Dimethyl Sulfoxide; Ib | 2011 |
Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Arthritis; Complement C5a; Drug Therapy, | 2002 |
[General practice study of back and joint pain. Good grades for a new nonsteroidal anti-inflammatory drug].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Back Pain; Humans; Ibuprofen; Patient Care Team; | 2002 |
I have arthritis and take ibuprofen. Can ibuprofen cause heart failure?
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Heart Failure; Humans; Ibuprofen | 2002 |
[Recognizing the "neck-tongue" syndrome].
Topics: Acetates; Amines; Analgesics; Analgesics, Non-Narcotic; Arthritis; Cervical Vertebrae; Cyclohexaneca | 2003 |
Ask the doctors. I have arthritis and take Motrin. Is there a problem with also taking aspirin, since my doctor has told me to do this ever since my heart attack?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Drug Interactions; Humans; Ibuprofen | 2003 |
Persistence with COX-2 inhibitors in managed care: an analysis of claims data.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 In | 2003 |
Nephrogenic adenoma of bladder after ibuprofen abuse.
Topics: Adenoma; Arthritis; Follow-Up Studies; Hematuria; Humans; Ibuprofen; Male; Middle Aged; Self Adminis | 2004 |
[Gastrointestinal complications under NSAID treatment in the doctor's office].
Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Clinical Trials as Topic; Dicl | 2004 |
[Ibuprofen is more effective and safer than paracetamol].
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Humans; Ibuprofen | 2006 |
Chondroitin sulfate-based anti-inflammatory macromolecular prodrugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Carrageenan; Chemical Phenomena; Chemis | 2006 |
Enhancement of antinociception by co-administration of ibuprofen and caffeine in arthritic rats.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Caffeine; Central Nervous S | 2006 |
Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular D | 2007 |
Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Clinical | 2007 |
Comparative effects of long term treatment with etodolac, naproxen and ibuprofen on articular and bone changes associated with adjuvant arthritis in rats.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Body Weight; Bone a | 1984 |
A clinical evaluation of the antiarthritic agents.
Topics: Anti-Inflammatory Agents; Antimalarials; Arthritis; Aspirin; Diflunisal; Fenoprofen; Glucocorticoids | 1984 |
Haptoglobin and copper in adjuvant arthritis during the ibuprofen therapy.
Topics: Animals; Arthritis; Arthritis, Experimental; Copper; Female; Haptoglobins; Ibuprofen; Male; Rats; Ra | 1984 |
Ro 10-9359, an aromatic retinoid in the treatment of psoriatic arthritis. Clinical and immunological studies.
Topics: Adult; Arthritis; Etretinate; Humans; Ibuprofen; Immunoglobulins; Lymphocytes; Male; Middle Aged; Ps | 1982 |
From arthritis pain to dysmenorrhea: a new indication for prostaglandin inhibitors.
Topics: Arthritis; Dysmenorrhea; Female; Humans; Ibuprofen; Mefenamic Acid; Prostaglandin Antagonists | 1980 |
Reintroduction of anti-inflammatory drug therapy after drug-associated gastro-intestinal disturbances.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Arthritis; Duodenal Ulcer; Female; Gastrointes | 1982 |
Current review and comparison of the new nonsteroidal anti-inflammatory agents.
Topics: Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Drug Administration Schedule; Fenoprofen | 1980 |
Antihypertensive effect of thiazides.
Topics: Aged; Arthritis; Drug Interactions; Humans; Hypertension; Ibuprofen; Male; Pindolol | 1981 |
Ibuprofen in psoriatic arthritis.
Topics: Arthritis; Ibuprofen; Psoriasis | 1980 |
Transsynovial distribution of ibuprofen in arthritic patients.
Topics: Adult; Aged; Arthritis; Blood Proteins; Fatty Acids, Nonesterified; Female; Humans; Ibuprofen; Male; | 1981 |
Effect of ibuprofen and diclofenac on the chemotaxis induced by substance P and transforming growth factor-beta on human monocytes and polymorphonuclear cells.
Topics: Arthritis; Chemotaxis; Diclofenac; Humans; Ibuprofen; In Vitro Techniques; Monocytes; Neutrophils; S | 1993 |
Inhibitory effect of NSAIDs on the chemotaxis induced by substance P on human monocytes and polymorphonuclear cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Chemotaxis, Leukocyte; Diclofenac; Huma | 1993 |
Patterns of prescription of nonsteroidal antiinflammatory drugs and gastroprotective agents.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Cohort Studies; Confide | 1995 |
[Schnitzler syndrome].
Topics: Arthritis; Autoantibodies; Biopsy; Bone Marrow; Fever of Unknown Origin; Humans; Ibuprofen; Immunogl | 1993 |
Drug-induced aseptic meningitis caused by two medications.
Topics: Arthritis; Female; Humans; Ibuprofen; Meningitis, Aseptic; Middle Aged; Trimethoprim, Sulfamethoxazo | 1994 |
I take ibuprofen regularly for my arthritis, but I've heard that it may lead to kidney damage. Can you tell me more?
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Humans; Ibuprofen; Kidney Diseases | 1999 |
[Influenza vaccine caused problems in joints. Compensation from the drug insurance authority].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; | 1999 |
[Side effects cause enormous costs. Expensive arthritis therapy].
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Butanones; Celecoxib; | 2001 |
Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase | 2002 |
Characterization of inhibitor(s) of lymphocyte activation in serum from rats with adjuvant arthritis.
Topics: Animals; Arthritis; Arthritis, Experimental; Chemical Fractionation; Chromatography, Gel; Concanaval | 1978 |
Ibuprofen-induced meningitis in systemic lupus erythematosus.
Topics: Adult; Antibodies, Antinuclear; Arthritis; Female; Humans; Ibuprofen; Lupus Erythematosus, Systemic; | 1978 |
Acute adverse reactions to ibuprofen in systemic lupus erythematosus.
Topics: Acute Disease; Adult; Arthritis; Drug Hypersensitivity; Female; Fever; Headache; Humans; Hypotension | 1979 |
Alopecia associated with ibuprofen.
Topics: Alopecia; Arthritis; Female; Humans; Ibuprofen | 1979 |
Comparison of the anti-inflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Female; Ibuprofen; Male; Myco | 1977 |
Haemolysis complicating ibuprofen treatment.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Arthritis; Female; Humans; Ibuprofen | 1978 |
Nonsteroidal anti-inflammatory drug treatment for arthritis.
Topics: Anti-Inflammatory Agents; Arthritis; Flufenamic Acid; Humans; Ibuprofen; Indomethacin; Mefenamic Aci | 1978 |
More on the new arthritis drugs.
Topics: Arthritis; Fenoprofen; Humans; Ibuprofen; Naproxen; Tolmetin | 1976 |
[Mumps arthritis].
Topics: Adult; Arthritis; Humans; Ibuprofen; Male; Mumps | 1975 |
Pharmacokinetics of the R(-) and S(+) enantiomers of ibuprofen in the serum and synovial fluid of arthritis patients.
Topics: Adult; Aged; Aged, 80 and over; Arthritis; Female; Humans; Ibuprofen; Male; Middle Aged; Stereoisome | 1991 |
Lofgren's syndrome (acute sarcoidosis) sine erythema nodosum mimicking acute rheumatoid arthritis.
Topics: Acute Disease; Adult; Arthritis; Arthritis, Rheumatoid; Diagnosis, Differential; Erythema Nodosum; F | 1990 |
[Concentrations of ibuprofen and the protein and pH value of synovial fluid and plasma following oral administration of ibuprofen in patients with arthritis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Arthritis; Female; Humans; Hydrogen-Ion Concentration | 1989 |
Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriatic arthropathy.
Topics: Adolescent; Arthritis; Drug Synergism; Drug Therapy, Combination; Female; Humans; Ibuprofen; Immunos | 1989 |
Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cartilage; Cattle; Cells, Cul | 1987 |
Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arthritis; Collagen; Dexamethasone; Ibuprofen; Imidazo | 1988 |
[Inhibitory effect of AD-1590, a non-steroidal anti-inflammatory drug, on allergic inflammation in mice and rats].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Dermatitis, Co | 1988 |
Agranulocytosis in a patient with psoriatic arthritis receiving auranofin and ibuprofen.
Topics: Adult; Agranulocytosis; Arthritis; Auranofin; Drug Therapy, Combination; Female; Humans; Ibuprofen; | 1987 |
Pharmacological studies of antigen-induced arthritis in BALB/c mice. I. Characterization of the arthritis and the effects of steroidal and non-steroidal anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Dexamethasone; Female; Flurbi | 1986 |
Proteolytic and beta-glucuronidase activity in adjuvant arthritis during the ibuprofen therapy.
Topics: Animals; Arthritis; Arthritis, Experimental; Female; Glucuronidase; Ibuprofen; Kinetics; Male; Pepti | 1985 |